PL357777A1 - Kompozycja farmaceutyczna zawierająca wapń, lub mieszaninę wapnia i witaminy D, lub mieszaninę wapnia i magnezu w nowej postaci - Google Patents

Kompozycja farmaceutyczna zawierająca wapń, lub mieszaninę wapnia i witaminy D, lub mieszaninę wapnia i magnezu w nowej postaci

Info

Publication number
PL357777A1
PL357777A1 PL01357777A PL35777701A PL357777A1 PL 357777 A1 PL357777 A1 PL 357777A1 PL 01357777 A PL01357777 A PL 01357777A PL 35777701 A PL35777701 A PL 35777701A PL 357777 A1 PL357777 A1 PL 357777A1
Authority
PL
Poland
Prior art keywords
calcium
mixture
vitamin
magnesium
content
Prior art date
Application number
PL01357777A
Other languages
English (en)
Inventor
Luboslav Razus
Juraj Wendl
Ivan Varga
Petr Simek
Original Assignee
Slovakofarma A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovakofarma A.S. filed Critical Slovakofarma A.S.
Publication of PL357777A1 publication Critical patent/PL357777A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL01357777A 2000-04-06 2001-03-15 Kompozycja farmaceutyczna zawierająca wapń, lub mieszaninę wapnia i witaminy D, lub mieszaninę wapnia i magnezu w nowej postaci PL357777A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SK498-2000A SK284948B6 (sk) 2000-04-06 2000-04-06 Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme

Publications (1)

Publication Number Publication Date
PL357777A1 true PL357777A1 (pl) 2004-07-26

Family

ID=20435843

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01357777A PL357777A1 (pl) 2000-04-06 2001-03-15 Kompozycja farmaceutyczna zawierająca wapń, lub mieszaninę wapnia i witaminy D, lub mieszaninę wapnia i magnezu w nowej postaci

Country Status (10)

Country Link
EP (1) EP1274447A1 (pl)
AU (1) AU2001239668A1 (pl)
BG (1) BG107227A (pl)
CZ (1) CZ303069B6 (pl)
EE (1) EE200200584A (pl)
MD (1) MD2722B2 (pl)
PL (1) PL357777A1 (pl)
RU (1) RU2002130196A (pl)
SK (1) SK284948B6 (pl)
WO (1) WO2001076610A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
DK2258349T3 (da) 2004-05-11 2014-10-13 Egalet Ltd Kvældbar doseringsform omfattende gellangummi
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
ATE538774T1 (de) * 2009-03-26 2012-01-15 Pulmatrix Inc Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen
AU2010229668C1 (en) 2009-03-26 2016-09-15 Pulmatrix Operating Co., Inc. Dry powder formulations and methods for treating pulmonary diseases
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
RU2017144619A (ru) 2010-09-29 2019-02-20 Пулмэтрикс, Инк. Катионы одновалентных металлов сухих порошков для ингаляций
WO2013130767A1 (en) 2012-02-29 2013-09-06 Pulmatrix, Inc. Inhalable dry powders
AU2014248455B2 (en) 2013-04-01 2018-12-06 Pulmatrix Operating Company, Inc. Tiotropium dry powders
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
RU2726438C2 (ru) * 2018-11-14 2020-07-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Способ получения сухой высокобелковой молочной смеси для профилактики остеопении у детей и подростков с целиакией
CN109453126A (zh) * 2018-12-07 2019-03-12 浙江核力欣健药业有限公司 一种碳酸钙d3咀嚼片的组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
CA1297035C (en) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Chewable, non-gritty calcium citrate tablet
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions
AU679020B2 (en) * 1992-12-23 1997-06-19 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US6241997B1 (en) * 1998-03-16 2001-06-05 Smtm Group. Llc Chewable calcium supplement and method

Also Published As

Publication number Publication date
AU2001239668A1 (en) 2001-10-23
MD20020265A (en) 2003-05-31
CZ303069B6 (cs) 2012-03-21
WO2001076610A1 (en) 2001-10-18
BG107227A (en) 2003-05-30
RU2002130196A (ru) 2004-03-27
MD2722B2 (ro) 2005-03-31
SK4982000A3 (en) 2001-10-08
EP1274447A1 (en) 2003-01-15
SK284948B6 (sk) 2006-03-02
EE200200584A (et) 2004-04-15

Similar Documents

Publication Publication Date Title
HUP0303434A3 (en) Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
PL357777A1 (pl) Kompozycja farmaceutyczna zawierająca wapń, lub mieszaninę wapnia i witaminy D, lub mieszaninę wapnia i magnezu w nowej postaci
HU9901570D0 (en) Use of nanodispersions in pharmaceutical compositions
AU2635201A (en) Direct manipulation of displayed content
HUP0302456A3 (en) Combination pharmaceutical compositions containing of amlodipine and benazepril and their use and preparation
CZ20011427A3 (cs) Farmaceutická kompozice s řízeným uvolňovaním obsahující inhibitor CGMP DPE-5
PL354315A1 (pl) Kompozycja kosmetyczna lub farmaceutyczna w postaci ciała stałego zawierająca bis-acyloamidy
IL145648A0 (en) Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
HU9901220D0 (en) Substituted tricyclic compounds and their use in pharmaceutical compositions
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
AU2002229616A1 (en) Improvements in and relating to the distribution of content
HUP0300539A3 (en) New pharmaceutical composition in form of emulsion preconcentrate
HUP0302099A3 (en) Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form
EP1292309A4 (en) PROPHYLACTIC AND THERAPEUTIC USE OF OLTIPRAZ AS AN AGENT AGAINST FIBROSIS AND CIRRUSH OF THE LIVER AND PHARMACEUTICAL COMPOSITION CONTAINING OLTIPRAZ
HU9901219D0 (en) Substituted tricyclic compounds and their use in pharmaceutical compositions
AU2001275821A1 (en) Anti-cancer composition composed of anti-cancer and anti-malarial drugs
GB9820815D0 (en) Improvementsin or relating to nutritional and pharmaceutical compositions
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
PL357020A1 (pl) Kompozycja
HUP0300557A3 (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
AU2002219949A1 (en) Dietary composition containing conjugated linoleic acid and calcium for improved health
GB0013503D0 (en) Pharmaceutical compositions and their uses
HUP0500956A2 (en) Oxapenem-3-carboxylic acids and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)